The Rationale for Use of Medical Suppressive Therapy Prior to Endoscopic Surgery

V C Buttram, Veasy C. Buttram
Annals of the New York Academy of Sciences · 1994 · vol. 734(1) , pp. 445–449 · doi:10.1111/j.1749-6632.1994.tb21774.x · PMID:7978946 · W2093487688
review OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reviews the rationale and evidence supporting the use of medical suppressive therapy before endoscopic surgery to manage conditions like endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Combined Modality Therapy Endometriosis Female Humans Postoperative Period Preoperative Care Tissue Adhesions

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (2)

References (6)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:24.284338+00:00
License: CC0 · commercial use OK